Israel’s Novocure has announced that its NovoTTF-100A portable scalp device extends the life of brain cancer patients. The device creates an alternating electric field and has had significant success in Phase 3 trials with patients receiving chemotherapy only.
http://www.haaretz.com/life/science-medicine/1.626964